世界の移植治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Transplantation Therapeutics Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4976 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、移植治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カルシニューリン阻害剤、抗増殖剤、コルチコステロイド、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・移植治療薬の市場動向 ・企業の競争状況、市場シェア ・移植治療薬の種類別市場規模と予測2016-2027（カルシニューリン阻害剤、抗増殖剤、コルチコステロイド、その他） ・移植治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・移植治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・移植治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・移植治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・移植治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・移植治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、GlaxoSmithKline、AbbVie、Pfizer、Astellas Pharma、Gilead Sciences、SBI Biotech、Sanofi、Takeda） ・結論

Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body.

Market Analysis and Insights: Global Transplantation Therapeutics Drugs Market
The global Transplantation Therapeutics Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transplantation Therapeutics Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transplantation Therapeutics Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transplantation Therapeutics Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transplantation Therapeutics Drugs market.

Global Transplantation Therapeutics Drugs Scope and Market Size
Transplantation Therapeutics Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transplantation Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Calcineurin Inhibitors
Anti-Proliferative Agents
Corticosteroids
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
GlaxoSmithKline
AbbVie
Pfizer
Astellas Pharma
Gilead Sciences
SBI Biotech
Sanofi
Takeda

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transplantation Therapeutics Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Calcineurin Inhibitors
1.2.3 Anti-Proliferative Agents
1.2.4 Corticosteroids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Transplantation Therapeutics Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Transplantation Therapeutics Drugs Market Perspective (2016-2027)
2.2 Transplantation Therapeutics Drugs Growth Trends by Regions
2.2.1 Transplantation Therapeutics Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Transplantation Therapeutics Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Transplantation Therapeutics Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Transplantation Therapeutics Drugs Industry Dynamic
2.3.1 Transplantation Therapeutics Drugs Market Trends
2.3.2 Transplantation Therapeutics Drugs Market Drivers
2.3.3 Transplantation Therapeutics Drugs Market Challenges
2.3.4 Transplantation Therapeutics Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Transplantation Therapeutics Drugs Players by Revenue
3.1.1 Global Top Transplantation Therapeutics Drugs Players by Revenue (2016-2021)
3.1.2 Global Transplantation Therapeutics Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Transplantation Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Transplantation Therapeutics Drugs Revenue
3.4 Global Transplantation Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Transplantation Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transplantation Therapeutics Drugs Revenue in 2020
3.5 Transplantation Therapeutics Drugs Key Players Head office and Area Served
3.6 Key Players Transplantation Therapeutics Drugs Product Solution and Service
3.7 Date of Enter into Transplantation Therapeutics Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Transplantation Therapeutics Drugs Breakdown Data by Type
4.1 Global Transplantation Therapeutics Drugs Historic Market Size by Type (2016-2021)
4.2 Global Transplantation Therapeutics Drugs Forecasted Market Size by Type (2022-2027)

5 Transplantation Therapeutics Drugs Breakdown Data by Application
5.1 Global Transplantation Therapeutics Drugs Historic Market Size by Application (2016-2021)
5.2 Global Transplantation Therapeutics Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Transplantation Therapeutics Drugs Market Size (2016-2027)
6.2 North America Transplantation Therapeutics Drugs Market Size by Type
6.2.1 North America Transplantation Therapeutics Drugs Market Size by Type (2016-2021)
6.2.2 North America Transplantation Therapeutics Drugs Market Size by Type (2022-2027)
6.2.3 North America Transplantation Therapeutics Drugs Market Size by Type (2016-2027)
6.3 North America Transplantation Therapeutics Drugs Market Size by Application
6.3.1 North America Transplantation Therapeutics Drugs Market Size by Application (2016-2021)
6.3.2 North America Transplantation Therapeutics Drugs Market Size by Application (2022-2027)
6.3.3 North America Transplantation Therapeutics Drugs Market Size by Application (2016-2027)
6.4 North America Transplantation Therapeutics Drugs Market Size by Country
6.4.1 North America Transplantation Therapeutics Drugs Market Size by Country (2016-2021)
6.4.2 North America Transplantation Therapeutics Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Transplantation Therapeutics Drugs Market Size (2016-2027)
7.2 Europe Transplantation Therapeutics Drugs Market Size by Type
7.2.1 Europe Transplantation Therapeutics Drugs Market Size by Type (2016-2021)
7.2.2 Europe Transplantation Therapeutics Drugs Market Size by Type (2022-2027)
7.2.3 Europe Transplantation Therapeutics Drugs Market Size by Type (2016-2027)
7.3 Europe Transplantation Therapeutics Drugs Market Size by Application
7.3.1 Europe Transplantation Therapeutics Drugs Market Size by Application (2016-2021)
7.3.2 Europe Transplantation Therapeutics Drugs Market Size by Application (2022-2027)
7.3.3 Europe Transplantation Therapeutics Drugs Market Size by Application (2016-2027)
7.4 Europe Transplantation Therapeutics Drugs Market Size by Country
7.4.1 Europe Transplantation Therapeutics Drugs Market Size by Country (2016-2021)
7.4.2 Europe Transplantation Therapeutics Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Transplantation Therapeutics Drugs Market Size (2016-2027)
8.2 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Type
8.2.1 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Application
8.3.1 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Region
8.4.1 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Transplantation Therapeutics Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Transplantation Therapeutics Drugs Market Size (2016-2027)
9.2 Latin America Transplantation Therapeutics Drugs Market Size by Type
9.2.1 Latin America Transplantation Therapeutics Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Transplantation Therapeutics Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Transplantation Therapeutics Drugs Market Size by Type (2016-2027)
9.3 Latin America Transplantation Therapeutics Drugs Market Size by Application
9.3.1 Latin America Transplantation Therapeutics Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Transplantation Therapeutics Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Transplantation Therapeutics Drugs Market Size by Application (2016-2027)
9.4 Latin America Transplantation Therapeutics Drugs Market Size by Country
9.4.1 Latin America Transplantation Therapeutics Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Transplantation Therapeutics Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Transplantation Therapeutics Drugs Market Size (2016-2027)
10.2 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Type
10.2.1 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Application
10.3.1 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Country
10.4.1 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Transplantation Therapeutics Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Transplantation Therapeutics Drugs Introduction
11.1.4 Novartis Revenue in Transplantation Therapeutics Drugs Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Transplantation Therapeutics Drugs Introduction
11.2.4 GlaxoSmithKline Revenue in Transplantation Therapeutics Drugs Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Transplantation Therapeutics Drugs Introduction
11.3.4 AbbVie Revenue in Transplantation Therapeutics Drugs Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Transplantation Therapeutics Drugs Introduction
11.4.4 Pfizer Revenue in Transplantation Therapeutics Drugs Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Details
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Transplantation Therapeutics Drugs Introduction
11.5.4 Astellas Pharma Revenue in Transplantation Therapeutics Drugs Business (2016-2021)
11.5.5 Astellas Pharma Recent Development
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Details
11.6.2 Gilead Sciences Business Overview
11.6.3 Gilead Sciences Transplantation Therapeutics Drugs Introduction
11.6.4 Gilead Sciences Revenue in Transplantation Therapeutics Drugs Business (2016-2021)
11.6.5 Gilead Sciences Recent Development
11.7 SBI Biotech
11.7.1 SBI Biotech Company Details
11.7.2 SBI Biotech Business Overview
11.7.3 SBI Biotech Transplantation Therapeutics Drugs Introduction
11.7.4 SBI Biotech Revenue in Transplantation Therapeutics Drugs Business (2016-2021)
11.7.5 SBI Biotech Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Transplantation Therapeutics Drugs Introduction
11.8.4 Sanofi Revenue in Transplantation Therapeutics Drugs Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Transplantation Therapeutics Drugs Introduction
11.9.4 Takeda Revenue in Transplantation Therapeutics Drugs Business (2016-2021)
11.9.5 Takeda Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Transplantation Therapeutics Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Calcineurin Inhibitors
Table 3. Key Players of Anti-Proliferative Agents
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Others
Table 6. Global Transplantation Therapeutics Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Transplantation Therapeutics Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Transplantation Therapeutics Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Transplantation Therapeutics Drugs Market Share by Regions (2016-2021)
Table 10. Global Transplantation Therapeutics Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Transplantation Therapeutics Drugs Market Share by Regions (2022-2027)
Table 12. Transplantation Therapeutics Drugs Market Trends
Table 13. Transplantation Therapeutics Drugs Market Drivers
Table 14. Transplantation Therapeutics Drugs Market Challenges
Table 15. Transplantation Therapeutics Drugs Market Restraints
Table 16. Global Transplantation Therapeutics Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Transplantation Therapeutics Drugs Market Share by Players (2016-2021)
Table 18. Global Top Transplantation Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transplantation Therapeutics Drugs as of 2020)
Table 19. Ranking of Global Top Transplantation Therapeutics Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Transplantation Therapeutics Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Transplantation Therapeutics Drugs Product Solution and Service
Table 23. Date of Enter into Transplantation Therapeutics Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Transplantation Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Transplantation Therapeutics Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Transplantation Therapeutics Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Transplantation Therapeutics Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Transplantation Therapeutics Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Transplantation Therapeutics Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Transplantation Therapeutics Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Transplantation Therapeutics Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Transplantation Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Transplantation Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Transplantation Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Transplantation Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Transplantation Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Transplantation Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Transplantation Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Transplantation Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Transplantation Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Transplantation Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Transplantation Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Transplantation Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Transplantation Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Transplantation Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Transplantation Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Transplantation Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Transplantation Therapeutics Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Transplantation Therapeutics Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Transplantation Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Transplantation Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Transplantation Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Transplantation Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Transplantation Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Transplantation Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Transplantation Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Transplantation Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Transplantation Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Transplantation Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Transplantation Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Transplantation Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Transplantation Therapeutics Drugs Product
Table 66. Novartis Revenue in Transplantation Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. GlaxoSmithKline Company Details
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Transplantation Therapeutics Drugs Product
Table 71. GlaxoSmithKline Revenue in Transplantation Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. AbbVie Company Details
Table 74. AbbVie Business Overview
Table 75. AbbVie Transplantation Therapeutics Drugs Product
Table 76. AbbVie Revenue in Transplantation Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 77. AbbVie Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Transplantation Therapeutics Drugs Product
Table 81. Pfizer Revenue in Transplantation Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Astellas Pharma Company Details
Table 84. Astellas Pharma Business Overview
Table 85. Astellas Pharma Transplantation Therapeutics Drugs Product
Table 86. Astellas Pharma Revenue in Transplantation Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 87. Astellas Pharma Recent Development
Table 88. Gilead Sciences Company Details
Table 89. Gilead Sciences Business Overview
Table 90. Gilead Sciences Transplantation Therapeutics Drugs Product
Table 91. Gilead Sciences Revenue in Transplantation Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 92. Gilead Sciences Recent Development
Table 93. SBI Biotech Company Details
Table 94. SBI Biotech Business Overview
Table 95. SBI Biotech Transplantation Therapeutics Drugs Product
Table 96. SBI Biotech Revenue in Transplantation Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 97. SBI Biotech Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Revenue in Transplantation Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 101. Sanofi Recent Development
Table 102. Takeda Company Details
Table 103. Takeda Business Overview
Table 104. Takeda Transplantation Therapeutics Drugs Product
Table 105. Takeda Revenue in Transplantation Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 106. Takeda Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transplantation Therapeutics Drugs Market Share by Type: 2020 VS 2027
Figure 2. Calcineurin Inhibitors Features
Figure 3. Anti-Proliferative Agents Features
Figure 4. Corticosteroids Features
Figure 5. Others Features
Figure 6. Global Transplantation Therapeutics Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Transplantation Therapeutics Drugs Report Years Considered
Figure 11. Global Transplantation Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Transplantation Therapeutics Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Transplantation Therapeutics Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Transplantation Therapeutics Drugs Market Share by Regions (2022-2027)
Figure 15. Global Transplantation Therapeutics Drugs Market Share by Players in 2020
Figure 16. Global Top Transplantation Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transplantation Therapeutics Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Transplantation Therapeutics Drugs Revenue in 2020
Figure 18. Global Transplantation Therapeutics Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Transplantation Therapeutics Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Transplantation Therapeutics Drugs Market Share by Type (2016-2027)
Figure 22. North America Transplantation Therapeutics Drugs Market Share by Application (2016-2027)
Figure 23. North America Transplantation Therapeutics Drugs Market Share by Country (2016-2027)
Figure 24. United States Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Transplantation Therapeutics Drugs Market Share by Type (2016-2027)
Figure 28. Europe Transplantation Therapeutics Drugs Market Share by Application (2016-2027)
Figure 29. Europe Transplantation Therapeutics Drugs Market Share by Country (2016-2027)
Figure 30. Germany Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Transplantation Therapeutics Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Transplantation Therapeutics Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Transplantation Therapeutics Drugs Market Share by Region (2016-2027)
Figure 40. China Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Transplantation Therapeutics Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Transplantation Therapeutics Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Transplantation Therapeutics Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Transplantation Therapeutics Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Transplantation Therapeutics Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Transplantation Therapeutics Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Transplantation Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Novartis Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2016-2021)
Figure 61. AbbVie Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2016-2021)
Figure 63. Astellas Pharma Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2016-2021)
Figure 64. Gilead Sciences Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2016-2021)
Figure 65. SBI Biotech Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2016-2021)
Figure 67. Takeda Revenue Growth Rate in Transplantation Therapeutics Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---